Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How Brand-Name Drugmakers Fight Generics
Pharmalot
Thursday, July 22, 2010 - 3:54pm
tags:
generics
A Sign of More Good Things to Come for Abbott
Motley Fool
Thursday, July 22, 2010 - 3:52pm
tags:
Abbott Laboratories
AstraZeneca Said to Pay $2 Million in Seroquel Cases
Bloomberg Businessweek
Thursday, July 22, 2010 - 3:51pm
tags:
settlements, AstraZeneca, antipsychotics, Seroquel
It's All About the Future for Amylin
Motley Fool
Thursday, July 22, 2010 - 3:49pm
tags:
Amylin, Bydureon, Byetta, diabetes, Novo Nordisk, Victoza, Merck, Januvia, Takeda, Actos, Onglyza, AstraZeneca
FDA asks NicOx for new naproxcinod trial
Fierce Biotech
Thursday, July 22, 2010 - 10:01am
tags:
FDA, NicOx, naproxcinod, osteoarthritis
What Investors Think About NeurogesX
Motley Fool
Thursday, July 22, 2010 - 9:59am
tags:
investors, NeurogesX
Avi BioPharma shares up on $291 mln U.S. accord
Marketwatch
Thursday, July 22, 2010 - 9:52am
tags:
AVI BioPharma, federal contracts
What Investors Think About Lannett
Motley Fool
Thursday, July 22, 2010 - 9:51am
tags:
Lannett, investors
FDA “must publish all safety, efficacy data from drug apps”
Pharma Times, UK
Thursday, July 22, 2010 - 9:45am
tags:
FDA, drug safety
Lawyers for about 5,200 current and former Sanofi-Aventis female sales reps ask for $15.36 million settlement in sex-bias case
Reuters
Thursday, July 22, 2010 - 9:40am
tags:
Sanofi, discrimination, settlements
Decision Resources: Only half of payers support biosimilar substitution
Drugstore News
Thursday, July 22, 2010 - 9:35am
tags:
biosimilars
Harvard puts tighter limits on medical faculty; restricts involvement with health care industry
Boston.com
Thursday, July 22, 2010 - 9:33am
tags:
Harvard, physician payments
Elan CEO Is Inept, Misleading & Should Go: Investor
Pharmalot
Thursday, July 22, 2010 - 9:30am
tags:
Elan, Pharma CEOs, Kelly Martin
Biotech Stock Mailbag: Ziopharm
TheStreet.com
Thursday, July 22, 2010 - 9:29am
tags:
Ziopharm, MELA Sciences, Vivus
Gilead Holding Up on Exhaustion of Negativity
Seeking Alpha
Thursday, July 22, 2010 - 9:27am
tags:
Gilead Sciences
Cephalon raises 2Q earnings, sales expectations
Yahoo/AP
Thursday, July 22, 2010 - 8:54am
tags:
Cephalon, earnings
Roche Profit Up on Genentech Synergies
NY Times, NY
Thursday, July 22, 2010 - 8:53am
tags:
Roche, earnings, M&A, Genentech
Milestones mitigate risk in biotech deals
Fierce Biotech
Thursday, July 22, 2010 - 8:51am
tags:
biotech, M&A, milestone payments
Endo Pharma Positions Itself For Post-Overhaul Health System
WSJ Online
Thursday, July 22, 2010 - 8:51am
tags:
Endo, healthcare reform
Glaxo To Pay $1B To Settle Paxil Birth Defect Cases
Pharmalot
Thursday, July 22, 2010 - 8:48am
tags:
settlements, Paxil, birth defects, GSK, antidepressants

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.